1.Therapeutic effect of the combined treatment of mecobalamin and salvia miltiorrhiza ligustrazine on diabetic peripheral neuropathy
Zhongmei JIANG ; Zhuanxin CHEN
Chinese Journal of Primary Medicine and Pharmacy 2015;(22):3467-3469
Objective To learn therapeutic effect of the combined treatment of mecobalamin and salvia milti-orrhiza ligustrazine on diabetic peripheral neuropathy.To provide effective and reliable operation method for the treat-ment of disease.Methods 163 cases with diabetic peripheral neuropathy were randomly divided into observation group(86 cases)and control group(77 cases).The observation group was treated with mecobalamin combined salvia miltiorrhiza ligustrazine,the control group was treated with mecobalamin.The sensory conduction velocity (SNCV) and motor conduction velocity (MNCV)were measured in the two groups before and after treatment.The therapeutic effects were evaluated after one course.Results The MNCV and SNCV of the two groups were higher than before treatment,the difference was statistically significant (t =24.298,25.546,18.737,15.733,14.284,14.886,9.337, 9.402,all P <0.05).The SNCV and MNCV in the observation group were significantly higher than those in the con-trol group (t =9.119,11.103,7.429,6.352,all P <0.05).The markedly effective rate of the observation group was 48.8% (42 /86),the total effective rate was 90.7% (78 /86),which were higher than those of the control group,the differences were statistically significant (χ2 =9.010,7.937,all P <0.05).The incidence rate of adverse reaction of the observation group was 5.8% (5 /86),which of the control group was 6.5% (5 /77),the difference was not statis-tically significant (χ2 =0.033,P >0.05).Conclusion In the treatment of diabetic peripheral neuropathy,the com-bined treatment of mecobalamin and salvia miltiorrhiza ligustrazine has better curative effect and low incidence rate of adverse reaction,with good clinical application value.
2.Clinical Research on Treatment of Oligospermia and Asthenospermia with Guiqishengjing Capsule
Yugang WANG ; Zhuanxin JIANG ; Jianhong YU ; Xiaodong WANG ; Ming SHEN ; Yunling QIN
Journal of Kunming Medical University 2013;(10):96-99
Objective To observe the clinical efficacy of Guiqi shengjing capsule on infertility caused by oligospermia and asthenospermia. Methods All of 126 oligospermia and asthenospermia outpatients in theDepartment of Andrology from Sep 2011 to Dec 2012 were divided into 2 groups randomly:experimental group and control group (63 patients in each group), which were taken Guiqishengjing capsule and Huangjing zanyu capsule respectively, with a course of 3 months. Then we observed and compared the clinical efficacy and semen parameters of the patients in the 2 groups before and after treatment. Results There was no significant differences in semen parameters between two groups before treatment ( >0.05) .And also there was no significant differences in total clinical effective rate and semen parameters between two groups after treatment ( >0.05) .But, the extremely significant difference presented in sperm activity and density before and after treatment in two groups (<0.01) . Conclusion Guiqishengjing capsule can promote spermatogenesis, improve sperm quality, and has definite effect on oligospermia and asthenospermia in infertility .
3.Curative Effect of Implantation of AMS Three-piece Inflatable Penile Prosthesis on Severe Erectile Dysfunction
Yunling QIN ; Zhuanxin JIANG ; Xiaodong WANG ; Yugang WANG ; Jianhong YU ; Ming SHEN
Journal of Kunming Medical University 2013;(10):69-72
Objective To observe the clinical efficacy of AMS three- piece inflatable penile prosthesis on erectile dysfunction (ED).Methods From Dec 2008 to Sep 2012, 7 patiens with of serve erectile dysfunction (ED),whose ages were 28~55 years (average 47 years) were implanted with AMS three- piece inflatable penile prosthesis in our hospital. The 7 patients with serve erectile dysfunction included 3 patients with neurogenic ED,2 patients with arteriovenous fistula in corpus cavernosum penis and 2 patients with fibrosis of corpus cavernosum penis. Results All of the patients were performed smoothly with implantation of AMS three- piece inflatable penile prosthesis, among them 3 cases appeared foreskin edema, but it disappeared after 2 weeks. After 6~36 months (average 18 months) follow up, there was no rejection, no implant failure, and no urethral injury in our group, all patients got satisfaction on sexual life, and one patient with arteriovenous fistula in corpus cavernosum penis after treatment made his wife pregnant. Conclusion AMS three- piece inflatable penile prosthesis is close to human physiological penis, it has good concealment, less surgical trauma , high success rate, satisfying clinical efficacy, safe and reliable mechanical behavior.